Implementation of a National Reference Laboratory for Buruli Ulcer Disease in Togo

PLoS Neglected Tropical Diseases

Volumn 7, Issue 1, 2013, Pages

  Beissner, Marcus ^a   Huber, Kristina Lydia ^a   Badziklou, Kossi ^b   Halatoko, Wemboo Afiwa ^b   Maman, Issaka ^b   Vogel, Felix ^c   Bidjada, Bawimodom ^b   Awoussi, Koffi Somenou ^b   Piten, Ebekalisai ^d   Helfrich, Kerstin ^a   Mengele, Carolin ^a   Nitschke, Jörg ^a,e   Amekuse, Komi ^e   Wiedemann, Franz Xaver ^e   Diefenhardt, Adolf ^e   Kobara, Basile ^b   Herbinger, Karl Heinz ^a   Kere, Abiba Banla ^b   Prince David, Mireille ^f   Löscher, Thomas ^a   Bretzel, Gisela ^a   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Ministry of Health   (Togo)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^d Centre Hospitalier Régional Maritime CHR Maritime   (Togo)

^e Klinikum der Ludwig Maximilians Universität München   (Togo)

^f UNIVERSITY OF LOMÉ   (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BACTERIAL DNA; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BURULI ULCER; CHILD; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DNA EXTRACTION; FEMALE; FINE NEEDLE ASPIRATES; HEALTH CARE PERSONNEL; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MYCOBACTERIUM ULCERANS; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SAMPLING; SCHOOL CHILD; TOGO; TRAINING;

EID: 84873517918     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002011     Document Type: Article

References (50)

1. Stienstra Y, van Roest MH, van Wezel MJ, Wiersma IC, Hospers IC, et al. (2005) Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health 10 (12): 1251-7.
2. World Health Organization (2006) Buruli Ulcer: Prevention of Disability (POD). Geneva: World Health Organization.
3. World Health Organization (2008) Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 83: 145-56.
4. Barogui Y, Johnson RC, van der Werf TS, Sopoh G, Dossou A, et al. (2009) Functional limitations after surgical or antibiotic treatment for Buruli ulcer in Benin. Am J Trop Med Hyg 81 (1): 82-7.
5. Schunk M, Thompson W, Klutse E, Nitschke J, Opare-Asamoah K, et al. (2009) Outcome of patients with buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana. Am J Trop Med Hyg 81 (1): 75-81.
6. Phanzu DM, Suykerbuyk P, Imposo DB, Lukanu PN, Minuku JB, et al. (2011) Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo. PLoS Negl Trop Dis 5 (12): e1402.
7. World Health Organization (2007) Summary report of the WHO annual meeting on Buruli ulcer, 2-4 April 2007 and Report of the Technical Advisory Group (TAG) meeting, 5 April 2007. Geneva: World Health Organization.
8. Johnson PD, Hayman JA, Quek TY, Fyfe JA, Jenkin GA, et al. (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186 (2): 64-8.
9. World Health Organization (2008) Meeting of the WHO Technical Advisory Group on Buruli ulcer, 3 April 2008, Geneva, Summary Report. Geneva: World Health Organization.
10. Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, et al. (2008) Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health 13: 191-8.
11. Affolabi D, Tanimomo-Kledjo B, Anyo G, Johnson RC, Anagonou SY, et al. (2008) Setting up a national reference laboratory for Buruli ulcer: the case of Benin. Trop Med Int Health 13 (3): 365-8.
12. Beissner M, Herbinger KH, Bretzel G, (2010) Laboratory diagnosis of Buruli ulcer disease. Future Microbiol 5 (3): 363-70.
13. Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, et al. (2011) Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010. PLoS Negl Trop Dis 7: e1228.
14. Portaels F, Agular J, Fissette K, Fonteyne PA, De Beenhouwer H, et al. (1997) Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 35: 1097-100.
15. Ross BC, Marino L, Oppendisano F, Edwards R, Robins-Browne RM, et al. (1997) Development of a PCR Assay for rapid Diagnosis of Mycobacterium ulcerans Infection. J Microbiol Clin 35 (7): 1696-700.
16. Guimaraes-Peres A, Portaels F, de Rijk P, Fissette K, Pattyn SR, et al. (1999) Comparison of two PCRs for detection of Mycobacterium ulcerans. J Clin Microbiol 37: 206-8.
17. Stinear T, Ross BC, Davies JK, Marino L, Robins-Browne RM, et al. (1999) Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 37 (4): 1018-23.
18. Stienstra Y, van der Werf TS, Guarner J, Raghunathan PL, Spotts Whitney EA, et al. (2003) Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J Clin Microbiol 41: 794-7.
19. Rondini S, Mensah-Quainoo E, Troll H, Bodmer T, Pluschke G, et al. (2003) Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA. J Clin Microbiol 41 (9): 4231-7.
20. Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, et al. (2004) Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg 70 (5): 520-6.
21. Siegmund V, Adjei O, Racz P, Berberich C, Klutse E, et al. (2005) Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic. J Clin Microbiol 43 (1): 271-6.
22. Phillips R, Horsfield C, Kuijper S, Lartey A, Tetteh I, et al. (2005) Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer. J Clin Microbiol 43 (8): 3650-6.
23. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson R, et al. (2006) External quality assurance for the laboratory diagnosis of Buruli ulcer disease in Ghana. Trop Med Int Health 11 (11): 1688-93.
24. Phanzu DM, Bafende EA, Dunda BK, Imposo DB, Kibadi AK, et al. (2006) Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg 75 (2): 311-4.
25. Siegmund V, Adjei O, Nitschke J, Thompson W, Klutse E, et al. (2007) Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease. Clin Infect Dis 45 (1): 68-75.
26. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, et al. (2007) A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 12 (1): 89-96.
27. Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, et al. (2007) Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73 (15): 4733-40.
28. Affolabi D, Bankolé H, Ablordey A, Hounnouga J, Koutchakpo P, et al. (2008) Effects of grinding surgical tissue specimens and smear staining methods on Buruli ulcer microscopic diagnosis. Trop Med Int Health 13 (2): 187-90.
29. Herbinger KH, Adjei O, Awua-Boateng NY, Nienhuis WA, Kunaa L, et al. (2009) Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48: 1055-64.
30. Kibadi K, Boelaert M, Fraga AG, Kayinua M, Longatto-Filho A, et al. (2010) Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS Negl Trop Dis 4 (7): e736.
31. Yeboah-Manu D, Asante-Poku A, Asan-Ampah K, Ampadu ED, Pluschke G, et al. (2011) Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer. Am J Trop Med Hyg 2011 Nov;85 (5): 900-4.
32. Affolabi D, Sanoussi N, Vandelannoote K, Odoun M, Faïhun F, et al. (2012) Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer). J Clin Microbiol 50 (4): 1195-8.
33. Meyers WM, Tignokpa N, Priuli GB, Portaels F, (1996) Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. Br J Dermatol 134: 1116-21.
34. Songné B, Abete B, Scotte M, Tignokpa N, Valenti P, (2001) [Buruli ulcer in Togo: 21 cases]. Presse Med 30: 533.
35. James K, Attipou KK, James YE, Blakime M, Tignokpa N, et al. (2003) [Buruli ulcer in Togo: a hospital study]. Sante 13: 43-47.
36. World Health Organization, Laboratory Support Network. Global network of laboratories for confirming Mycobacterium ulcerans infection (Buruli ulcer). Geneva: World Health Organization. Available: http://www.who.int/buruli/Global_network_laboratories_PCR.pdf. Accessed 16 July 2012.
37. Herbinger KH, Brieske D, Nitschke J, Siegmund V, Thompson W, et al. (2009) Excision of pre-ulcerative forms of Buruli Ulcer Disease: A curative treatment? Infection 14 37: 20-5.
38. Eddyani M, Fraga AG, Schmitt F, Uwizeye C, Fissette K, et al. (2009) Fine needle aspiration, an efficient sampling technique for the bacteriological diagnosis of nonulcerative Buruli ulcer lesions. J. Clin. Microbiol 47: 1700-04.
39. Phillips RO, Sarfo FS, Osei-Sarpong F, Boateng A, Tetteh I, et al. (2009) Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol 47: 924-26.
40. Herbinger KH, Beissner M, Huber K, Awua-Boateng NY, Nitschke J, et al. (2010) Efficiency of fine-needle aspiration compared with other sampling techniques for laboratory diagnosis of Buruli ulcer disease. J Clin Microbiol 48 (10): 3732-4.
41. World Health Organization (2010) Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease). Geneva: World Health Organization.
42. World Health Organization (2001) Diagnosis of Mycobacterium ulcerans disease. Geneva: World Health Organization.
43. Beissner M, Symank D, Phillips RO, Amoako YA, Awua-Boateng NY, et al. (2012) Detection of Viable Mycobacterium ulcerans in Clinical Samples by a Novel Combined 16S rRNA Reverse Transcriptase/IS2404 Real-Time qPCR Assay. PLoS Negl Trop Dis 6 (8): e1756.
44. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg Infect Dis 10 (8): 1391-8.
45. Coulibaly B, Coulibaly-N'Golo MD, Ekaza E, Aka N, N'Guessan KR, Baudryard A, et al. (2010) [Implementation of in vitro culture of Mycobacterium ulcerans from clinical samples versus detection of acid-fast bachilli and bacterial genome in Abidjan, Côte d'Ivoire]. Bull Soc Pathol Exot 103 (1): 2-7.
46. Minime-Lingoupou F, Beyam N, Zandanga G, Manirakiza A, N'Domackrah A, et al. (2010) Buruli ulcer, Central African Republic. Emerg Infect Dis 16 (4): 746-8.
47. APHL, CDC, IUATLD, KNCV, RIT & WHO (2002) External quality assessment of AFB smear microscopy. APHL, Washington D.C.
48. WHO (2004) Resolution WHA57.1. Surveillance and control of Mycobacterium ulcerans disease (Buruli ulcer). In: Fifty-seventh World Health Assembly, Geneva, 17-22 May 2004. Resolutions and decisions Geneva: World Health Organization. WHA57/2004/REC/1:1-2.
49. Kiefer T, Hirt C, Schüler F, Busemann C, Wodny M, et al. (2012) Statistical analysis of results obtained by real-time PCR for improvement of absolute quantification of target sequences. Clin Lab 58 (5-6): 465-70.
50. WHO (2009) Cotonou Declaration on Buruli Ulcer. Geneva: World Health Organization.